Product
DBI-001
3 clinical trials
3 indications
Indication
Athlete's FootIndication
Nail FungusIndication
Atopic DermatitisClinical trial
An Observer-Blinded, Randomized, Aqueous Gel Controlled Trial of the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Interdigital Tinea PedisStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Clinical trial
An Observer-Blinded, Randomized, Aqueous Gel-Controlled Trial of the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With OnychomycosisStatus: , Estimated PCD: 2023-11-30
Clinical trial
A Randomized, Observer-Blinded, Within Patient Bilateral Comparison to Study the Safety and Efficacy of Daily Application for 4 Weeks of DBI-001 Gel Versus Aqueous Gel in Subjects With Atopic DermatitisStatus: Terminated, Estimated PCD: 2022-09-09